Tiazofurin is a synthetic nucleoside analogue with antineoplastic activity. Tiazofurin (TR) is anabolized intracellularly to an analogue of NAD, tiazole-4-carboxamide adenine dinucleotide (TAD), a potent inhibitor of IMP dehydrogenase (IMPDH); IMPDH is the rate-limiting enzyme for de novo purine synthesis. Inhibition of IMPDH results in reduced levels of guanylates, resulting in the inhibition tumor cell growth in vitro and in vivo. Its therapeutic use is listed as antineoplastics. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Riboxamide, Tiazofurinum and TCAR. Its PubChem CID is 457954.
Tiazofurin
| CAS No | 60084-10-8 |
|---|---|
| Molecular Formula | C9H12N2O5S |
| Molecular Weight | 260.27 g/mol |
| Synonyms | 2-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3-thiazole-4-carboxamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Tiazofurin is a synthetic nucleoside analogue with antineoplastic activity. Tiazofurin (TR) is anabolized intracellularly to an analogue of NAD, tiazole-4-carboxamide adenine dinucleotide (TAD), a potent inhibitor of IMP dehydrogenase (IMPDH); IMPDH is the rate-limiting enzyme for de novo purine synthesis.
The listed CAS number is 60084-10-8.
The listed molecular formula is C9H12N2O5S.
The listed molecular weight is 260.27 g/mol.
2-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3-thiazole-4-carboxamide.
The source lists Riboxamide, Tiazofurinum and TCAR.